Arcadia Biosciences, Inc. (RKDA)
$0.20-4.76%Close
SELLCRISIS · day 18
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $309,463
- Beta
- 0.55
- P/E (TTM)
- -0.02
- Short % float
- 4.96%
- Days to cover
- 1.0
- SI change
- +824.0%
- 1W
- -31.03%
- 1M
- -53.49%
- vs SPY 1W
- -30.90%
- vs SPY 1M
- -55.99%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 14
- GROWTH
- 24
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-203.9%
REV YoY-
ROE-339.9%
EPS YoY-
ROA-188.9%
GROSS35
OP-86
NET-235
[VALUATION]
P/E TTM-0.02
P/E FWD-
SECTOR PE25.12
INDUSTRY PE0.00
P/B0.43
P/FCF-
EV/EBITDA0.35
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO3.49
ND/EBITDA-
BETA0.55
Company news
FAQ
- What is LOPJLB’s current signal on RKDA?
- LOPJLB’s latest quantitative signal on Arcadia Biosciences, Inc. (RKDA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is RKDA in?
- Arcadia Biosciences, Inc. (RKDA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Arcadia Biosciences, Inc. (RKDA) do?
- Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a particular focus on improving wheat crops. The aim of these innovations is to enhance farmers' economic stability by boosting crop performance in the field, increasing their value for food and wellness…